MedTrace Logo

Citalopram vs Clomipramine vs Placebo in Recurrent Depression

NCT01575158 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2012-04-11

No results posted yet for this study

Summary

citalopram and clomipramine are better than placebo in preventing new episodes of depression in patients with recurrent depression

Conditions

Interventions

DRUG

Citalopram

DRUG

Clomipramine

DRUG

placebo

Sponsors & Collaborators

  • Danish University Antidepressant Group

    collaborator UNKNOWN

  • University of Aarhus

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-10-31
Primary Completion
2007-09-30
Completion
2007-09-30

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01575158 on ClinicalTrials.gov